Painful |
Subacute granulomatous | Infection (viral) | Subacute | Hyper, hypo, or both, then normal | < 5 percent | Low or absent titer | Four to five cases per 100,000 persons |
Suppurative | Infection (nonviral) | Acute (nonbacterial may be subacute) | Normal | Normal | Absent | Undetermined but very rare |
Radiation or trauma | Destruction of thyroid parenchyma | Acute | Hyper, hypo, or normal | < 5 percent | Absent* | 1 percent of those receiving131I for Graves' disease |
Painless |
Hashimoto's disease | Autoimmune | Chronic | Normal or hypo | Normal or low | High titer, persistent | 5 to 10 percent |
Postpartum | Autoimmune | Subacute | Hyper, hypo, or both, then normal | < 5 percent | High titer, persistent | 5 to 7 percent of postpartum women |
Subacute lymphocytic | Autoimmune | Subacute | Hyper, hypo, or both, then normal | < 5 percent | Present, persistent | 10 to 15 cases per 100,000 persons |
Drug-induced |
| Amiodarone (Cordarone) | Inflammation | Acute or subacute | Hyper or hypo | Low | Absent | 10 percent |
| Interferon-alfa (Infergen; Intron A, Roferon-A, Rebetron combination therapy) | Inflammation | Acute or subacute | Hyper or hypo | Low | 5 to 10 percent positive | 10 to 15 percent |
| Interleukin-2 | Inflammation | Acute or subacute | Hyper or hypo | Low | < 10 percent positive | Undetermined |
| Lithium | Autoimmune | Acute or subacute | Hyper then normal, or low | Low | 33 percent positive | 13 cases per 100,000 persons |
Riedel's | Fibrosis | Chronic | Normal or low | Normal or low | Present | Undetermined |